Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age

Pediatrics

Volumn 118, Issue 3, 2006, Pages 978-984

  Gustafsson, Lennart ^a   Hessel, Luc ^b   Storsaeter, Jann ^c   Olin, Patrick ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b SANOFI PASTEUR   (France)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Acellular pertussis vaccines; Immunization schedule; Surveillance

Indexed keywords

PERTUSSIS VACCINE; BACTERIAL DNA;

AGE SPECIFIC CARE; ARTICLE; BACTERIUM CULTURE; CHILD; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWEDEN; VACCINATION; FEMALE; HEALTH SURVEY; IMMUNIZATION; MALE; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; MALE; PERTUSSIS VACCINE; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; SWEDEN; WHOOPING COUGH;

EID: 33749050408     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2746     Document Type: Article

References (17)

1. Taranger J, Trollfors B, Bergfors E, et al. Mass vaccination of children with pertussis toxoid: decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis. 2001;33:1004-1009
2. Salmaso S, Mastrantonio P, Tozzi AE, et al. Sustained efficacy during first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pedatrics. 2001;108(5). Available at: www.pediatrics.org/cgi/content/full/108/5/e81
3. Lugauer S, Heininger U, Cherry JD, Stehr S. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell component vaccine. Eur J Pediatr. 2002;161:142-146
4. Olin P, Gustafsson L, Barreto L, et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine. 2003;21:2015-2021
5. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States 1980-1989. Clin Infect Dis. 1992;14:708-719
6. Crowcroft NS, Britto J. Whooping cough: a continuing problem. BMJ. 2002;324:1537-1538
7. Wirsing von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis. 2002;2(12):744-50
8. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23:985-989
9. Bisgard KM, Rhodes P, Connelly B, et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics. 2005;116:285-294
10. Elliott E, McIntyre P, Ridley G, et al. National study of infants hospitalised with pertussis in the acellular era. Pediatr Infect Dis J. 2004;23:246-252
11. Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H, for the Ad Hoc Group for the Study of Pertussis Vaccines. Randomised controlled trial of two-component, three-component and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet. 1997;350:1569-1577
12. World Health Organization. WHO Meeting on Case Definition of Pertussis: Report of the Meeting. MIN/EPI/PET/91. January 10-11, 1991. Geneva, Switzerland: World Health Organization; 1:4-5
13. Timion ON, Hanlon M. Acellular vaccines for preventing whooping cough in children [Cochrane Review]. In: The Cochrane Library. Issue 4. Oxford, United Kingdom: Update Software; 2001
14. Romanus V, Jonsell R, Bergquist SO. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J. 1987;6:364-371
15. Carlsson R-M, Ekholm L, Gothefors L, Granström M, Trolin I, Tegnell A. Time for booster doses against whooping cough at 10 years of age [in Swedish]. Läkartidningen. 2005;102:2394-2398
16. Forsyth KD, Campins-Marti M, Caro J, et al. New pertussis vaccination strategies beyond infancy: Recommendations by the global pertussis initiative. Clin Infect Dis. 2004;39:1802-1809
17. Norrby R. Time to change the immunizations of children. Swedish children may be better protected against disease but to a higher price [in Swedish] Läkartidningen. 2005;102:2376-2378